REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,997.50
Bid: 2,050.00
Ask: 2,060.00
Change: 0.00 (0.00%)
Spread: 10.00 (0.488%)
Open: 1,997.50
High: 0.00
Low: 0.00
Prev. Close: 1,997.50
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement and Notice of Results

9 Feb 2023 07:00

RNS Number : 3588P
S & U PLC
09 February 2023
 

9th February 2023

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT AND NOTICE OF RESULTS

 

S&U plc, the specialist motor and property finance lender, today issues its trading update for the period from its trading statement of 8 December 2022 to the Group's year end on 31 January 2023. S&U's full year results will be announced on 28 March 2023.

 

Our last trading update of 8 December recorded our expectation that the "very good" trading and receivable quality we reported then would be carried over for the rest of the financial year. So it has happily proved. Current trading in both businesses, Advantage, our motor finance lender, and Aspen, our property bridging lender, remains excellent. This will be reflected in the full year's results which are expected to both meet expectations and exceed budget.

 

These results are the more meritorious for being achieved against a background of "political and economic uncertainty" as we reported in December. Despite a slight uptick recently in UK consumer confidence, UK business confidence is reported by the ICAEW to be a thirteen year low whilst a potential recession and rising interest rates continue to pose challenges.

 

Nevertheless, S&U continues to grow and perform well. Despite the period seeing prudent adjustments to underwriting and the scorecard, and some rate increases to protect net interest margins as both operational and financial costs grow, group net receivables have now reached c£420m against £370m at the half year. That ultimate measure of quality - collections - remains good in both businesses.

 

 

Motor Finance

The used car market, in which Advantage operates, remains active with pricing remaining strong. As new car sales recover to January 2020 levels, used car prices have increased on average over 20% in the past eighteen months. Used car sales volumes consistently stood at 250,000 vehicles per month over the same eighteen month period.

 

Advantage's experience reflects these trends. Transaction levels are likely to reach nearly 24,000 this year, an increase of 21% on 2021/2022. Transaction numbers in the period were near record levels. This year the usual sales lull of December did not occur. Tightened credit criteria has led to a shift towards a nearer prime customer so that average loan size rose by just over 9% to £7,800 per deal.

 

High receivables quality was demonstrated by collections against due finishing above budget for the year at an impressive 94%. Both bad debts and voluntary terminations continue to remain below budget and monthly live collections exceeded £14m for the first time in January 2023.

 

Net receivables at Advantage were c£306m, 18% up on last year. This growth was driven by transaction numbers, an increase in deal size and marginally longer terms for higher scoring customers. Whilst interest rates, on average, were marginally lower in the period to attract a higher quality customer profile, this higher initial quality will help further underpin our collections and profit during the potentially more uncertain economic times ahead. Customer numbers have reached 65,000 for the first time.

 

 

Aspen Bridging

Aspen, our property finance business, continues to make progress, albeit at a slower pace commensurate with recent trends in the UK housing market. House prices have now been reported to have fallen for five consecutive months, whilst mortgage approvals and transaction activity have been restricted by rising interest rates and cost of living pressures.

 

These trends are expected to continue during 2023. Prudence has therefore dictated further rises in Aspen's own interest rate and tightening of its already conservative loan-to-value requirements. Nevertheless, such is Aspen's credibility with its introducer partners and its reputation for bespoke and flexible lending, that its net receivables have risen slightly from £108m to £114m in the period.

 

Repayment quality remains good. Of 141 loans on the books, Aspen currently has only one case in repossession and just four customers are more than 60 days overdue. Although the re-mortgage market has slowed, both in size and transactions, the overall quality of Aspen's loan book means that profits exceed budget.

 

 

Funding

Recent growth at Advantage has seen Group net borrowings for the period rise from £180m to £192m. Whilst the pace of this expansion is likely to abate, in order to support growth and following the increase in our facilities in September, it is likely we will add further to our current £210m committed facilities during H1 23. Although Group gearing is therefore expected to increase from its traditionally modest level, currently c86%, this will remain moderate and, as always, carefully monitored.

 

 

Dividend

Irrespective of the fluctuations and recent volatility of the stock market, S&U's policy is to ensure that its commercial success is reflected in its shareholders' income. We have therefore sought to maintain, on average, a twice covered dividend policy even in the roller coaster years of COVID. This year we therefore propose a second interim dividend of 38p per ordinary share (2022: 36p), payable on 10 March to shareholders on the register on 17 February.

 

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said: "Whilst the uncertainties of forecasting and fly casting have much in common, 2023 is likely to see constrained levels of consumer confidence and spending in the UK. Nevertheless, historically this has and, I believe, will continue to present good, responsible, lending opportunities for S&U. We will take advantage of these with the same agility, prudence and imagination which has served S&U so well for so long."

 

 

For further information, please contact:

 

 

Enquiries

Anthony Coombs

 

S&U plc

c/o SEC Newgate

 

Financial Public Relations

Bob Huxford, Molly Gretton, Harry Handyside

 

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Adrian Trimmings, Sam Milford

 

Peel Hunt LLP

020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGCPUPWGQR
Date   Source Headline
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.